Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 6,041 | 6,206 | 5,687 | 5,760 | 6,277 |
| Operating Income | -6,041 | -6,206 | -5,687 | -5,760 | -6,277 |
| Interest Expense | 71 | 111 | 261 | 295 | 291 |
| Other Income | 170 | 76 | 88 | 58 | 63 |
| Pre-tax Income | -5,942 | -6,241 | -5,860 | -5,997 | -6,505 |
| Net Income Continuous | -5,942 | -6,241 | -5,860 | -5,997 | -6,505 |
| Net Income | $-5,942 | $-6,241 | $-5,860 | $-5,997 | $-6,505 |
| EPS Basic Total Ops | -2.00 | -3.15 | -3.50 | -5.60 | -6.30 |
| EPS Basic Continuous Ops | -1.98 | -3.03 | -3.47 | -5.50 | -6.31 |
| EPS Diluted Total Ops | -2.00 | -3.15 | -3.50 | -5.60 | -6.30 |
| EPS Diluted Continuous Ops | -1.98 | -3.03 | -3.47 | -5.50 | -6.31 |
| EBITDA(a) | $-6,034 | $-6,139 | $-5,643 | $-5,709 | $-6,227 |